ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study americanpharmaceuticalreview
February 14, 2019Pulmatrix announced the US Food and Drug Administration (FDA) completed its review of our Investigational New Drug (IND) Application and notified the Company that we are authorized to initiate a Phase 2 clinical investigation for ...
Pharma Sources Insight January 2025
